
Alvotech S.A (ALVOW) | Stock Overview & Key Data
Alvotech S.A Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $91.50 on May 2, 2022
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Financial Highlights
Profitability
Returns and Earnings
Growth
Peer Performance Comparison
Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
---|---|---|---|---|---|---|---|---|---|
Alvotech S.A ALVOW | 543.25M Small-cap | -13.48% | 0.65% | 10.79% | -51.27% | -49.84% | -30.50% | -97.79% | -97.79% |
Zoetis ZTS | 68.99B Large-cap | -1.33% | -6.84% | 3.69% | -6.83% | -4.70% | -13.45% | -11.22% | 7.12% |
Haleon Plc - ADR HLN | 44.30B Large-cap | -5.14% | -8.67% | -6.16% | 3.79% | 1.59% | 8.75% | 30.77% | 30.77% |
Indivior PLC INDV | 1.95B Small-cap | 5.14% | 17.36% | 79.36% | 38.71% | 29.28% | 49.86% | 333.33% | 940.00% |
BGM BGM | 1.79B Small-cap | -0.10% | -23.72% | -12.27% | 1.05% | 7.94% | 53.47% | 1.06% | -78.29% |
Supernus SUPN | 1.85B Small-cap | 1.36% | 3.90% | 9.20% | -11.00% | -7.80% | 10.81% | 10.08% | 43.99% |
Ownership & Short Interest
Alvotech S.A Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Alvotech S.A would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is ALVOW's 52-week high and low?
- In the last 52 weeks, Alvotech S.A reached a high of $4.99 (on January 8, 2025) and a low of $1.02 (on May 7, 2025).
- What is the market cap and P/E ratio for ALVOW?
- Curious about Alvotech S.A's size and valuation? Its market capitalization stands at 543.25M. When it comes to valuation, the P/E ratio (trailing twelve months) is N/A, and the forward P/E (looking ahead) is N/A.
- Does ALVOW pay dividends? If so, what's the yield?
- As for dividends, Alvotech S.A isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Alvotech S.A's main competitors or similar companies to consider before investing?
When looking at Alvotech S.A, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Zoetis
ZTS68.99B Healthcare Drug Manufacturers - Specialty & Generic -13.45% -11.22% Haleon Plc - ADR
HLN44.30B Healthcare Drug Manufacturers - Specialty & Generic 8.75% 30.77% Indivior PLC
INDV1.95B Healthcare Drug Manufacturers - Specialty & Generic 49.86% 333.33% BGM
BGM1.79B Healthcare Drug Manufacturers - Specialty & Generic 53.47% 1.06% Supernus
SUPN1.85B Healthcare Drug Manufacturers - Specialty & Generic 10.81% 10.08% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Alvotech S.A.? (e.g., ROE, Debt/Equity)
- To get a sense of Alvotech S.A's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 56.17%, the Debt to Equity ratio from the most recent quarter is -4.06, and its Gross Profit Margin stands at 50.70%.
- What is the recent revenue and earnings growth for ALVOW?
- Looking at Alvotech S.A's growth, its revenue over the trailing twelve months (TTM) was $588M. Compared to the same quarter last year (YoY), quarterly revenue grew by 260.00%, and quarterly earnings saw a YoY growth of 260.27%.
- How much of ALVOW stock is held by insiders and institutions?
- Wondering who owns Alvotech S.A stock? Company insiders (like executives and directors) hold about N/A of the shares, while institutional investors (such as mutual funds and pension funds) own approximately N/A.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.